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Background: Haemophilus influenzae is an opportunistic bacterial pathogen that exclusively colonises humans and
is associated with both acute and chronic disease. Despite its clinical significance, accurate identification of H.
influenzae is a non-trivial endeavour. H. haemolyticus can be misidentified as H. influenzae from clinical specimens
using selective culturing methods, reflecting both the shared environmental niche and phenotypic similarities of
these species. On the molecular level, frequent genetic exchange amongst Haemophilus spp. has confounded
accurate identification of H. influenzae, leading to both false-positive and false-negative results with existing
speciation assays.
Results: Whole-genome single-nucleotide polymorphism data from 246 closely related global Haemophilus isolates,
including 107 Australian isolate genomes generated in this study, were used to construct a whole-genome
phylogeny. Based on this phylogeny, H. influenzae could be differentiated from closely related species. Next, a H.
influenzae-specific locus, fucP, was identified, and a novel TaqMan real-time PCR assay targeting fucP was designed.
PCR specificity screening across a panel of clinically relevant species, coupled with in silico analysis of all species
within the order Pasteurellales, demonstrated that the fucP assay was 100 % specific for H. influenzae; all other
examined species failed to amplify.
Conclusions: This study is the first of its kind to use large-scale comparative genomic analysis of Haemophilus spp.
to accurately delineate H. influenzae and to identify a species-specific molecular signature for this species. The fucP
assay outperforms existing H. influenzae targets, most of which were identified prior to the next-generation
genomics era and thus lack validation across a large number of Haemophilus spp. We recommend use of the fucP
assay in clinical and research laboratories for the most accurate detection and diagnosis of H. influenzae infection
and colonisation.
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The Gram-negative Haemophilus spp. bacteria comprise
a diverse group containing at least 12 currently recog-
nised species, all of which are commensal or pathogenic
to humans or animals. Haemophilus influenzae is the
best-known member of this genus, particularly serotybe
b (Hib), the leading cause of invasive bacterial disease in
children prior to the introduction of the first licensed
Hib conjugate vaccine in 1987 [1]. In regions where Hib
vaccination has been implemented, the spectrum of se-
vere Hib disease is now close to eradication [2]. Other
H. influenzae serotypes (a; c-f ), and nonencapsulated,
“nontypeable” H. influenzae (NTHi), which are not tar-
geted by the Hib vaccine, are now recognised as import-
ant causes of primarily mucosal acute and chronic
infections [3]. NTHi is a common coloniser of the upper
respiratory tract in healthy individuals but can cause oti-
tis media, conjunctivitis, sinusitis, and lower respiratory
infections in children, exacerbations of chronic obstruct-
ive pulmonary disease (COPD) and cystic fibrosis (CF)
in adults, and sepsis in neonates and immunocomprom-
ised adults [4]. Although far less common than H. influ-
enzae, other Haemophilus species also have the potential
to cause human disease including H. haemolyticus, H.
parainfluenzae, H. aegyptius (a biogroup of H. influen-
zae), H. pittmaniae, H. parahaemolyticus and H. para-
phrohaemolyticus [5–14].
Misidentification of near-neighbour Haemophilus species
as H. influenzae has broad-ranging implications for clinical
diagnosis, reported carriage rates and assessment of disease
outcomes from antibiotic or vaccine clinical trials.
Microbiological differentiation of H. influenzae from
other species has conventionally relied upon colonial
morphology, haemin and NAD (X and V factor) depend-
ence, and for capsular strains, serotyping using various
methods [15]. For NTHi, identification relies on the ab-
sence of capsule and is thus more challenging than cap-
sulated H. influenzae. In 2007, Murphy and colleagues
were the first to report the misidentification of non-
haemolytic strains of H. haemolyticus as NTHi [16].
These strains are phenotypically indistinguishable from
NTHi and represent the only other Haemophilus spp.
for which X and V factor dependence is a diagnostic
criterion.
Numerous genetic methods for discriminating H. influ-
enzae from other species have been described [16–23].
However, accurate delineation of H. influenzae from
other Haemophilus species using genetic methods has
proven challenging. Recombination between H. influen-
zae and other Haemophilus spp., particularly H. haemoly-
ticus [17, 22, 24], has confounded molecular speciation
attempts, especially in the absence of genomic data. Binks
and colleagues [22] recently assessed the ability of a num-
ber of published and novel PCR-based methods todiscriminate NTHi from closely-related Haemophilus spe-
cies compared with recA and 16S rRNA gene sequencing,
and reported that an assay targeting sequence diversity
within the hpd gene, which encodes for Protein D, was su-
perior to other molecular signatures. Additionally, the
hpd#3 assay was specific for H. influenzae when compared
against a panel of common respiratory bacteria and has
been used to quantify H. influenzae directly from clinical
specimens [22]. However, we recently reported the ab-
sence of hpd in a proportion of H. influenzae isolates,
which was only identified following whole-genome se-
quencing analysis of 20 NTHi isolates [25]. This finding
highlights both the limitation of hpd for H. influenzae de-
tection and the requirement for genomic data spanning a
comprehensive Haemophilus dataset to identify a “gold
standard” molecular signature.
Here, we describe a large-scale comparative genomics
approach comprising 246 closely related, global Hae-
mophilus spp. isolates to identify loci unique to H. influ-
enzae. One of these loci, fucP, was used to develop a
real-time PCR assay targeting H. influenzae. PCR screen-
ing of the fucP assay across 59 genome-sequenced Aus-
tralian Haemophilus spp. isolates and 35 clinically




Whole-genome analysis of the isolates in this study was
covered by the Human Research Ethics Committee of the
Northern Territory Department of Health and Menzies
School of Health Research, approval numbers 07/63 and
07/85, and the Princess Margaret Hospital for Children
Ethics Committee, approval number 1295/EP.
Bacterial isolates
A total of 511 isolates were examined in this study, the
majority of which were Haemophilus spp. (Table 1).
Haemophilus isolates originated from a wide range of
clinical sites, clinical conditions and geographic regions.
Samples were obtained from nasopharyngeal swabs, spu-
tum, bronchoalveolar lavage, throat, or blood specimens,
and include isolates sourced from either healthy carriers
or cases of otitis media, bronchiectasis, protracted bac-
terial bronchitis, chronic obstructive pulmonary disease
and bacteraemia.
Two-hundred and forty-six closely related Hae-
mophilus isolates (H. influenzae, H. haemolyticus and
a novel ‘fuzzy’ Haemophilus species) had whole-
genome data available for this study (Fig. 1; Additional
file 1). Our dataset included 87 unique global NTHi
isolates from Brazil, China, Czech Republic, Finland,
Ghana, Iceland, Malaysia, Papua New Guinea, South
Africa, South Korea, Spain, Sweden, United Kingdom
Table 1 Bacterial isolates and genomic data used in this study
Species No. strains
(no. with genome data)
Haemophilus influenzae,
incl. NTHi and biogroup
aegyptiusa
338 (201)
Haemophilus haemoglobinophilus 1 (1)
Haemophilus haemolyticusb 107 (32)
Haemophilus parahaemolyticus 2 (1)


















































aSpecies determined according to a positive fucP assay result and/or by
whole-genome sequencing
bSpecies determined by a negative fucP result, a positive H. haemolyticus hpd
HRM result [27], and/or by whole-genome sequencing
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European Nucleotide Archive database (http://www.e-
bi.ac.uk/ena/). The current study generated a further
107 Australian Haemophilus spp. genomes (Additional
file 1). The remaining 52 genomes were downloaded
from the NCBI public Nucleotide data repository
(http://www.ncbi.nlm.nih.gov/nucleotide/) or the Se-
quence Read Archive database (http://www.ncbi.nlm.-
nih.gov/sra). Amongst the 246 genomes were 201 H.
influenzae (comprising 186 NTHi, 11 capsulated
strains, three Biogroup aegyptius strains and one
strain with unspecified capsular status) and 32 H. hae-
molyticus isolates. Thirteen isolates from our Austra-
lian laboratories that possessed X and V factor
dependence but could not be definitively speciated by
whole-genome sequencing were classed as Haemophi-
lus spp. (Additional file 1). Two-hundred and twelve
additional Australian Haemophilus spp. designated as
H. influenzae or H. haemolyticus using the hpd PCR
high-resolution melt (HRM) assay [27], one each of H.
parahaemolyticus and H. parainfluenzae, and 40 non-
Haemophilus isolates (Table 1) were tested by fucP
PCR only.
Phenotypic selection of the Australian Haemophilus
spp. isolates was undertaken prior to molecular speci-
ation. Only clinically-derived isolates that were both X
and V factor-dependent and that failed to react with
capsular antisera using the Phadebact® Haemophilus
coagglutination test (MKL Diagnostics, Sweden) were
selected for further analysis. Of the 107 Australian Hae-
mophilus isolates that underwent genome sequencing,
18 were not speciated by molecular methods, 15 were
speciated using 16S rDNA sequencing [16], and the re-
mainder underwent molecular speciation using hpd-
based methods [22, 27].
Isolates were subcultured for purity through a mini-
mum of three passages prior to DNA extraction. The
Qiagen DNeasy kit (Qiagen, Doncaster, VIC, Australia)
was used for DNA extraction according to the manufac-
turer’s instructions, with enzymatic pre-treatment as de-
scribed previously [28]. DNA was quality-checked for
purity and extraction efficiency using a NanoDrop 2000
spectrophotometer (Thermo Fisher Scientific, Scoresby,
Fig. 1 Genome-based differentiation of Haemophilus influenzae from closely-related species. A midpoint-rooted maximum parsimony phylogeny
was constructed using genomic data from 246 global, closely related Haemophilus spp. isolates, 107 of which were Australian Haemophilus isolates
sequenced in the present study. Phylogenetic reconstruction of 63,447 orthologous, core genome, bi-allelic single-nucleotide polymorphisms
(SNPs) enabled differentiation of nontypeable and serotypeable H. influenzae (blue text) from H. haemolyticus (red text) and other “fuzzy”
Haemophilus species (green text). ‘Clade I’ H. influenzae, which are genetically distinct from other H. influenzae [26], are denoted by purple
text. NTHi strains encoding capsular loci that are not expressed (according to [26]) are denoted by an asterisk. The H. haemolyticus and
“fuzzy” strains share the same ecological niches as H. influenzae and are indistinguishable from H. influenzae based on morphological
characteristics including X and V factor dependency. Bootstrap values are shown for major branches. Consistency index = 0.14. NB. More distantly
related Haemophilus species (H. haemoglobinophilus, H. parahaemolyticus, H. parainfluenzae and H. paraphrohaemolyticus) were excluded to maximise
core genome size
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molecular-grade H2O prior to PCR.
H. influenzae whole-genome sequencing
Paired-end genomic data for the Australian isolates
were generated using the HiSeq or MiSeq platforms(Illumina, Inc., San Diego, CA, USA), and were
sequenced by Macrogen Inc. (Geumcheon-gu, Seoul,
Republic of Korea). The comparative genomics pipe-
line SPANDx v2.6 [29] was used to analyse the Hae-
mophilus genomes (Additional file 1). Input data for
SPANDx were already in paired-end Illumina format,





824000..828000c 4 fucP, fucA, fucU, fucK, fucI (partial) (fucose
transport and degradation)
829000..830000 1 fucI (partial), fucR
(fucose transport and degradation)
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were first converted to synthetic paired-end Illumina
reads with ART (version VanillaIceCream) [30] using
quality shifts of 10. The closed NTHi 86-028NP gen-
ome [31] was used as the reference for short-read
alignment mapping. Synthetic reads for 86-028NP
were included as a control.1617000..1623000 6 pstS, pstC, pstA, pstB, phoB, phoR
(phosphate binding and regulation)
1795000..1796000 1 pdxS, dpxT (glutamine metabolism)
aBased on the NTHi 86-028NP (RefSeq: NC_007146) genome [31]
bResolution to 1 kb. Only those regions with 100 % coverage across all H.
influenzae genomes and <50 % coverage in other Haemophilus spp. genomes
are shown
cfucP was chosen for this studyPhylogenetic analysis
Species boundaries for H. influenzae and H. haemolyti-
cus were established a posteriori following phylogenetic
reconstruction of 63,447 high-confidence orthologous,
core genome, bi-allelic single-nucleotide polymorphisms
(SNPs) identified across 246 closely related Haemophilus
genomes. Genomes from more distantly related species
(H. parainfluenzae, H. haemoglobinophilus, H. parahae-
molyticus and H. paraphrohaemolyticus) were excluded
from this analysis to maximise the core genome size. No
additional SNP filtering (e.g. to exclude recombined re-
gions) was performed. Maximum parsimony trees were
generated using PAUP* 4.0b10 [32]; bootstrapping was
based on 200 replicates. Trees were visualised using Fig-
Tree v1.4.0 (http://tree.bio.ed.ac.uk/software/figtree/).Identification of H. influenzae-specific signatures
We deliberately chose not to pursue SNPs for H. influ-
enzae speciation due to the high risk of eventually en-
countering a homoplastic event [33]. This risk is greatly
increased in highly recombinogenic species like H.
influenzae. Instead, we aimed to identify discrete, H.
influenzae-specific genetic loci for assay design. To
identify such loci, the coverageBed module of BED-
Tools v2.18.2 [34], which is part of the SPANDx pipe-
line, was applied across the 246 closely related
Haemophilus genomes as described previously [35],
using default settings. This tool performs presence/ab-
sence analysis of Illumina reads for all genomes against
the reference genome. MS Excel 2013 was used to visu-
alise presence/absence outputs. Candidate H. influen-
zae-specific loci were identified by filtering for regions
with 100 % read coverage in the target species but with
<50 % coverage in outgroup strains. Using this ap-
proach, three candidate loci ≥4 kb were identified
(Table 2). One locus, fucP (NTHI0865 in 86-028NP),
which encodes L-fucose permease, was chosen for real-
time PCR assay design as this region was highly con-
served amongst the 201H. influenzae genomes. The
coverageBED output was also used to assess presence/
absence of the following previously reported H. influen-
zae-specific targets: fucK (NTHI0870 in 86-028NP [18]),
hap (NTHI0354 [18]), hpd (NTHI0811 [21, 22, 27]), iga
(NTHI1164 [17]), lgtC (NTHI0365 [17]), ompP2
(NTHI0225 [36]) and ompP6 (NTHI0501 [37]).H. influenzae real-time PCR assay
The fucP assay was used to complement our hpd results
due to the recent observation that some Australian H.
influenzae strains lack full-length hpd, and can therefore
be erroneously genotyped with this assay [25]. Unlabelled
primers fucP-F (5′-GCCGCTTCTGAGGCTGG) and
fucP-R (5′-AACGACATTACCAATCCGATGG) (Sigma-
Aldrich, Castle Hill, NSW, Australia) were designed to
generate a 68-bp fragment. A TaqMan probe (fucP-Probe:
5′-6FAM TCCATTACTGTTTGAAATAC-MGBNFQ; Life
Technologies, Grand Island, NY, USA) was included to in-
crease specificity and to provide a “gold standard” PCR
methodology for clinical specimens. Microbial discontigu-
ous MegaBLAST analysis (http://blast.ncbi.nlm.nih.gov/;
analysis performed 28-Dec-14) of the H. influenzae fucP
amplicon across 3,546 complete microbial genomes, 10,247
Proteobacterial draft genomes and 1,734 complete plasmid
genomes (total: 15,527 genomes) confirmed locus specifi-
city, with a 100 % match in all H. influenzae (including
biogroup aegyptius) at both primer- and probe-binding
sites, and several primer and probe mismatches in the next
closest species match (the avian pathogen Avibacterium
paragallinarum [38]; two nucleotide mismatches in the for-
ward primer, four mismatches in the reverse primer and
one mismatch in the TaqMan probe). No other Haemophi-
lus spp. yielded a detectable BLAST result for the fucP
amplicon, indicating the absence of this locus in other
species.
Real-time PCRs were performed using the RotorGene
6000 (Qiagen, Chadstone, VIC, Australia) and ABI PRISM
7900HT (Life Technologies, Mulgrave, VIC, Australia)
platforms. Each reaction contained 0.25 μM of each pri-
mer, 0.1 μM of probe and 1 μL genomic DNA. For the
RotorGene 6000 instrument, 1X Platinum PCR SuperMix
(Life Technologies) was used to a total reaction volume of
10 μL. For the 7900HT instrument, 1X TaqMan Universal
Master Mix (Life Technologies) and 384-well plates were
used, enabling 5 μL reaction volumes. The 317 isolates
tested by PCR in this study (Table 1; includes 46H.
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jected to whole-genome sequencing) were assessed in du-
plicate, and all runs contained appropriate positive control
and no-template control reactions. For both instruments,
thermocycling was carried out as follows: 50 °C for 2 min,
95 °C for 10 min, followed by 45 cycles of 95 °C for 5 sec
(15 sec for the ABI PRISM) and 60 °C for 5 sec (1 min for
the ABI PRISM). The green/FAM channels were used for
fluorescence detection.
Results and discussion
This study is the first to use extensive whole-genome se-
quence data from global Haemophilus isolates to identify
and design a highly accurate molecular assay targeting H.
influenzae. Based on microbiological characteristics alone,
H. influenzae, and particularly NTHi, cannot always be
differentiated from non-haemolytic H. haemolyticus [16]
or closely related “fuzzy” Haemophilus species. Molecular
methods are therefore essential for accurate identification
of H. influenzae. However, assay design has conventionally
been thwarted by high levels of recombination between H.
influenzae and other Haemophilus species, and has even
been documented between Haemophilus and Neisseria
meningitidis [39]. Compounding this issue is the lack of
rigorous, comparative in silico analysis of putative molecu-
lar signatures using large-scale whole-genome sequence
data. These inherent obstacles with accurate H. influenzae
speciation have likely led to underreporting of false-
positive and false-negative results for this clinically im-
portant bacterium [16, 22].
To address this issue, we combined whole-genome
data generated for 107 Australian strains by our labora-
tory with all closely related Haemophilus spp. genome
data available in the public domain, including 87 unique
NTHi genomes from De Chiara et al. [26], to identify a
highly specific signature for H. influenzae. Species
boundaries were first established a posteriori using
phylogenetic analysis of 246 Haemophilus genomes
(Fig. 1). Based on this analysis, 201 of these strains were
identified as H. influenzae, 32 as H. haemolyticus and 13
as possible novel “fuzzy” Haemophilus species (Fig. 1).
This phylogeny was highly similar to a recent whole-
genome phylogeny constructed using 97 predominantly
NTHi strains [26]. Amongst the 107 Australian Hae-
mophilus spp. isolates subjected to whole-genome se-
quencing, 89 had prior speciation data by PCR-based
methods [16, 22, 27]. Interestingly, the genome phyl-
ogeny reassigned two NTHi isolates that had previously
been identified by 16S rDNA PCR (n = 1) [16] or hpd#3
PCR (n = 1) [22] as H. haemolyticus, and reassigned 10
NTHi, one H. haemolyticus, and two equivocal isolates
as a potentially novel “fuzzy” Haemophilus species.
Following species delineation on a whole-genome SNP
level, loci specific to H. influenzae were located. Coregenome analysis of the 201H. influenzae genomes found
that 936 kb was conserved amongst all H. influenzae
strains, represented by 100 % read coverage across all H.
influenzae genomes; however, across the larger 246 Hae-
mophilus genome dataset, only a minute fraction (12 kb)
was unique to H. influenzae (Table 2). This very low
prevalence of H. influenzae-specific loci exemplifies the
inherent difficulties in molecular speciation of this bacter-
ium, particularly in lieu of whole-genome data. Four loci,
ranging from 1 to 6 kb in size, were identified as H. influ-
enzae-specific (Table 2). A 4 kb locus, part of a fucose
transport and degradation operon, was selected for assay
design due to high sequence conservation across all H.
influenzae isolates. Within this locus we targeted the L-
fucose permease-encoding gene, fucP [40]. L-fucose per-
mease is a pH-dependent major facilitator superfamily
transporter that uptakes L-fucose, a substrate that can act
as a sole carbon source for bacteria [41]. In the human
host, the fucose operon may impart a competitive advan-
tage and virulence potential to H. influenzae, as has been
documented in Campylobacter jejuni [42].
Following its design and in silico validation (as de-
tailed in Methods), the fucP TaqMan real-time PCR
assay was screened for specificity against 35 bacterial
species (comprising 40 isolates) of clinical relevance
(Table 1). As expected, only H. influenzae amplified
using the fucP assay. A further selection of 212 nasopha-
ryngeal, bronchoalveolar lavage and throat isolates, pre-
viously designated H. influenzae or H. haemolyticus
using the hpd PCR high-resolution melt (HRM) assay
[27], were screened using the fucP assay; 124/137 (91 %)
hpd-defined H. influenzae isolates and 0/75 hpd-defined
H. haemolyticus isolates amplified with the fucP assay.
Subsequent genomic analysis of 10 of the 14 presump-
tive NTHi isolates that failed fucP PCR confirmed they
are neither H. influenzae nor H. haemolyticus, but rather
represent a possible novel “fuzzy” Haemophilus species
(Fig. 1, green text). An additional three Haemophilus iso-
lates (H18, H40 and H180) not screened with the hpd
HRM assay also grouped with this “fuzzy” Haemophilus
species based on whole-genome phylogenetic analysis.
The remaining four isolates were not whole-genome se-
quenced in this study, but we suspect that they will also
group with the “fuzzy”, fucP-negative, hpd HRM H.
influenzae-positive isolates. We plan to genome-
sequence these strains in the future to confirm their
phylogenetic placement.
Several H. influenzae-specific molecular targets have
been reported previously and include fucK, hap, hpd,
iga, lgtC, ompP2 and ompP6. In the current study, we
compared the presence/absence profiles of these loci
across our Haemophilus genome dataset. The fucP and
fucK loci were best at differentiating H. influenzae from
closely-related species, demonstrating 100 % specificity
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closely related “fuzzy” Haemophilus isolates with H.
influenzae, and were absent in H. haemolyticus. The
hap, hpd and omp loci were least effective at differentiat-
ing H. influenzae from near-neighbour species, with po-
tential false-positives and negatives for hpd, hap and
ompP2, and false-positives for ompP6 (Fig. 2).
These findings are noteworthy given that the hpd tar-
get in particular has gained popularity due to its pur-
ported ability to differentiate H. influenzae from H.
haemolyticus [e.g. [27, 43, 44]]. We recently reported
that the hpd “gold standard” PCR target for H. influen-
zae identification is absent in some NTHi strains, an ob-
servation only made possible by the provision of
genomic data [25]. The non-essential hpd gene encodes
Protein D immunoglobulin, the H. influenzae compo-
nent of the multivalent Synflorix vaccine [45]. Therefore,
targeted selection pressure towards H. influenzae may
have contributed to the emergence of vaccine escape
variants in recent years. In support of our previous find-
ings, we found that 6 % of NTHi and 23 % of H. haemo-
lyticus strains lack hpd (Fig. 2). Based on our genomic
analysis, we no longer recommend the use of hpd for
detection or differentiation of H. influenzae and H.
haemolyticus.
The fucK locus, like fucP, appears to be an excellent
target for H. influenzae speciation (Fig. 2). Other studies
have identified fucose operon-negative H. influenzae
strains [40, 46], a concerning finding given that fucK is
one of seven loci used in the H. influenzae multilocus
sequence typing scheme (http://pubmlst.org/hinfluenzae/;
[47]). Our data suggest that the fucose operon may con-
stitute an essential metabolic pathway in H. influenzae,
contrary to these earlier reports. In the absence ofFig. 2 Genomic comparison of fucP with existing Haemophilus influenzae
a 1 kb locus window; yellow, between 50 and 99 % read coverage; green
intermediate Haemophilus specieswhole-genome data, it seems likely that fucK-negative
H. influenzae strains are in fact H. haemolyticus or closely-
related “fuzzy” species that have been misidentified using
lower-resolution genotyping methods. In such cases, the
identification of fucP- or fucK-negative strains should be
seen as an opportunity to investigate species designation
with higher-resolving methods such as whole-genome
sequencing, and should not be judged as a failure of the
assays to detect H. influenzae.
Nevertheless, it cannot be reasonably expected that
a single assay will accurately speciate all H. influenzae all
the time. First, there is the possibility for as-yet-
unobserved SNPs to eventually be encountered in the fucP
primer and probe binding sites, leading to poor amplifi-
cation of certain H. influenzae isolates and resultant
false-negatives or ambiguous genotype calls. As a sali-
ent example, using BLAST we identified three SNPs
residing within a published fucK black-hole quencher
probe [37]: one SNP in H. influenzae 10810 and two
SNPs in KR494. This assay, which like fucP has been
designed for H. influenzae detection in real-time PCR
using a fluorogenic probe, would be expected to ad-
versely affect amplification in H. influenzae strains
harbouring these SNPs. Second, amplification of H.
parahaemolyticus, H. parainfluenzae and Pasteurella
multocida has been observed using a probeless fucK
PCR [22] due to fucK orthologues in these species,
leading to false-positive calls. Third, high rates of lat-
eral gene transfer within and amongst Haemophilus
species, combined with insufficient diversity in certain
loci (e.g. 16S rDNA), will eventually lead to false-
positive results and erroneous species assignments, es-
pecially when based on a single gene or locus. All of
these possibilities demonstrate that large-scale genome-specific targets. Red, <50 % Illumina paired-end read coverage across
, >99 % read coverage. Hi, H. influenzae; Hh, H. haemolyticus, “fuzzy”,
Price et al. BMC Genomics  (2015) 16:641 Page 8 of 10datasets, extensive in silico validation efforts and the in-
clusion of fluorogenic probes targeting highly con-
served regions are important considerations when
designing H. influenzae-specific PCR assays to maxi-
mise specificity. Others have used the strategy of inter-
rogating multiple genetic loci to improve species
determination [5, 17]. Similarly, in instances where
100 %H. influenzae detection is essential, we recom-
mend that two or more independent and well-validated
assays, or ideally whole-genome sequencing coupled
with phylogenetic analysis, should be used to verify
species assignment.
One recognised limitation of this study is that, despite
analysing whole-genome sequencing data, the delinea-
tion of Haemophilus species boundaries remains some-
what arbitrary. In particular, the exclusion of the “fuzzy”
clade from the H. influenzae group is potentially conten-
tious given that these isolates share a node with ‘Clade I’
H. influenzae [26], and thus may in fact represent a
novel H. influenzae clade rather than a distinct species.
However, for the purposes of this study, these “fuzzy”
isolates were classified as distinct from H. influenzae
due to their relatively high dissimilarity on the nucleo-
tide level (only 94–98 % sequence identity in ortholo-
gous regions) and their unclear clinical relevance. In the
absence of extensive transcriptional, metabolic and DNA
hybridisation analysis of these isolates, we have chosen
not to classify these isolates as H. influenzae. This ap-
proach does not diminish the value of the fucP assay for
H. influenzae identification; rather, it highlights a deficit
in our current understanding of Haemophilus diversity
and the need for greater genomic, transcriptomic and meta-
bolic studies within this genus. Interestingly, the hpd HRM
assay grouped these “fuzzy” isolates with H. influenzae on
100 % of occasions, suggesting close relatedness of these
species, although it remains unclear whether hpd HRM
genotypes are variable in “fuzzy” isolates as has been ob-
served in NTHi. On a crude presence/absence level, the
iga or lgtC loci also provided good detection of H. influ-
enzae and “fuzzy” isolates to the exclusion of H. haemo-
lyticus (Fig. 2). Closer investigation of conserved regions
within these or similar loci will enable detection of the
“fuzzy” species clade and H. influenzae as a single group.
We are currently investigating suitable targets for this
purpose.
Conclusions
We have used a large-scale genomic approach to char-
acterise the highly recombinogenic Haemophilus spp.,
including 107 new isolates from Australia. This ap-
proach enabled accurate delineation of H. influenzae
from morphologically identical near-neighbour species.
Using extensive genomic data, we next designed and
validated a real-time PCR assay targeting the fucP locusin H. influenzae, which provided 100 % specificity for
this bacterium both in silico and across a diverse bac-
terial DNA panel. The fucP TaqMan assay format en-
ables rapid testing of clinical specimens, leading to
faster and more accurate diagnosis of this bacterium
without the requirement for culture.
Availability of supporting data
Eight Australian reference genomes (comprising two H.
influenzae, three H. haemolyticus and three Haemophi-
lus sp.) that support the results of this article are avail-
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